{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:14:49Z","timestamp":1773922489351,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jviromet.2013.06.019","type":"journal-article","created":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T17:14:45Z","timestamp":1371748485000},"page":"166-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cytomegalovirus load in whole blood is more reliable for predicting and assessing CMV disease than pp65 antigenaemia"],"prefix":"10.1016","volume":"193","author":[{"given":"Diana R.","family":"Hardie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen N.J.","family":"Korsman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nei-yuan","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2013.06.019_bib0005","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1128\/JCM.40.5.1581-1586.2002","article-title":"Distinguishing cytomegalovirus (CMV) infection and disease with CMV nucleic acid assays","volume":"40","author":"Caliendo","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2013.06.019_bib0010","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jcv.2012.10.001","article-title":"CMV antigenemia and quantitative viral load assessments in hematopoietic stem cell transplant recipients","volume":"56","author":"Carde\u00f1oso","year":"2013","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jviromet.2013.06.019_bib0015","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/1545109710366180","article-title":"Human cytomegalovirus infection among patients living with AIDS in a tertiary level hospital in India","volume":"9","author":"Chakravarti","year":"2010","journal-title":"J. Int. Assoc. Physicians AIDS Care"},{"key":"10.1016\/j.jviromet.2013.06.019_bib0020","unstructured":"Freyer, J.F., Heath, A.B., Anderson, R., Minor, P.D., 2010. Collaborative Study Group: Collaborative study to evaluate the proposed 1st WHO International standard for Human Cytomegalovirus for nucleic acid amplification based assays. WHO\/BS\/10.2138, Geneva, 18-22 October 2010, p 1\u201340."},{"key":"10.1016\/j.jviromet.2013.06.019_bib0025","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.bmt.1705986","article-title":"Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipients","volume":"41","author":"Gerna","year":"2008","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.jviromet.2013.06.019_bib0030","first-page":"4","article-title":"Monitoring transplant patients for human cytomegalovirus: diagnostic update","volume":"13","author":"Gerna","year":"2006","journal-title":"Herpes"},{"key":"10.1016\/j.jviromet.2013.06.019_bib0035","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ppul.21228","article-title":"CMV pneumonia in HIV-infected ventilated infants","volume":"45","author":"Goussard","year":"2010","journal-title":"Pediatr. Pulm"},{"key":"10.1016\/j.jviromet.2013.06.019_bib0040","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/cid\/cis212","article-title":"Interpreting quantitative cytomegalovirus DNA testing: understanding the laboratory perspective","volume":"54","author":"Kraft","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jviromet.2013.06.019_bib0045","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1182\/blood-2007-03-080820","article-title":"Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemia","volume":"110","author":"Lilleri","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jviromet.2013.06.019_bib0050","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.bmt.1704369","article-title":"Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation","volume":"33","author":"Mori","year":"2004","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.jviromet.2013.06.019_bib0055","first-page":"99","article-title":"Cytomegalovirus co-infection in patients with HIV\/AIDS in north India","volume":"117","author":"Mujtaba","year":"2003","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.jviromet.2013.06.019_bib0060","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1128\/JCM.41.7.3167-3174.2003","article-title":"LightCycler-based PCR, COBAS amplicor CMV monitor, and pp65 antigenemia assays for quantitative measurement of cytomegalovirus viral load in peripheral blood","volume":"41","author":"Pang","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2013.06.019_bib0065","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcv.2003.12.010","article-title":"Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients","volume":"30","author":"Piiparinen","year":"2004","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jviromet.2013.06.019_bib0070","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1172\/JCI1633","article-title":"In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia","volume":"101","author":"Revello","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jviromet.2013.06.019_bib0075","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/(SICI)1096-9071(199607)49:3<195::AID-JMV6>3.0.CO;2-#","article-title":"Significance of cytomegalovirus (CMV)-pp65 antigenemia in the diagnosis of CMV disease in human immunodeficiency virus-infected patients","volume":"49","author":"Reynes","year":"1996","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jviromet.2013.06.019_bib0080","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/01.tp.0000183970.71366.da","article-title":"Pre-emptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients","volume":"81","author":"Strippoli","year":"2006","journal-title":"Transplantation"}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093413002334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093413002334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:28:55Z","timestamp":1539563335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093413002334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0166093413002334"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2013.06.019","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytomegalovirus load in whole blood is more reliable for predicting and assessing CMV disease than pp65 antigenaemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2013.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}